Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noscapine for cough treatment in mild outpatient COVID-19
IRCT20151227025726N31Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diphenhydramine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Response time to treatment, Time to cough resolution and 4 more. Started Jun 2022; status: completed.
02
Drugs
diphenhydramine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20151227025726N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N31.